Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Envarsus 4 mg prolonged-release tablets

Active Ingredient:
tacrolimus monohydrate
Company:  
Chiesi Limited See contact details
ATC code: 
L04AD02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Product Information Safety Alert HCP Med Info
{arrow_left}
{arrow_right}
Updated prescribing information

Following a review by the Commission on Human Medicines (CHM), updated advice on the prescribing and dispensing of oral tacrolimus products has been agreed. This updated advice is that all oral tacrolimus medicines in the UK should be prescribed and dispensed by brand name only.

Further information:

MHRA press release

Letter sent to healthcare professionals

Questions and answers document

Chiesi Limited
Company image
Address
Chiesi Limited, 333 Styal Road, Manchester, M22 5LG
WWW
http://www.chiesi.uk.com
Telephone
0800 009 2329
Telephone
+44 (0) 161 488 5555
Medical Information Direct Line
+44 (0)1748 827 271
Medical Information e-mail
[email protected]
Product Quality Complaints
[email protected]
Stock Availability
[email protected]
Stock Availability
www.chiesi.uk.com/supply-of-chiesi-products
Medical Information Website
https://www.chiesimedical.co.uk
Drug Safety e-mail
[email protected]